NCT06725355

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of IN-R00002 and IN-G00002 in Healthy Adult Volunteers

• Status: Active Not Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

To compare the pharmacokinetics and safety after a single dose administration of IN-G00002 and IN-R00002 in healthy adult volunteers

Detailed description

A randomized, open-label, single-dose, crossover study

Conditions

• Non-valvular Atrial Fibrillation (NVAF)

Interventions

Type	Name	Description
DRUG	IN-R00002	Single administration of IN-R00002 60mg
DRUG	IN-G00002	Single administration of IN-G00002 60mg

Timeline

• Start date: 2024-08-16
• Primary completion: 2024-10-08
• Completion: 2025-01-14
• First posted: 2024-12-10
• Last updated: 2024-12-10

Locations

1 site across 1 country: South Korea